Surface modification of G4 and G5 PAMAM dendrimers

被引：0
|
作者：
Girten, Craig D. [1 ]
Helton, Jody R. [1 ]
Tomalia, Donald A. [2 ]
Martines, Kristi H. [3 ]
Bullen, Heather A. [1 ]
Walters, Keith A. [1 ]
机构：
[1] No Kentucky Univ, Dept Chem, Highland Hts, KY 41099 USA
[2] Dendrit NanoTechnol Inc, Mt Pleasant, MI 48858 USA
[3] No Kentucky Univ, Dept Biol Sci, Highland Hts, KY 41099 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 233卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
487-CHED
引用
收藏
页码：679 / 679
页数：1
相关论文
共 50 条
  • [31] 金河田G5
    电脑迷, 2008, (19) : 27 - 27
  • [32] 比亚迪G5
    卫东
    汽车与运动, 2014, (12) : 38 - 41
  • [33] Thermodynamic investigation of G2 and G4 siloxane dendrimers with trimethylsilyl terminal groups
    Sologubov, Semen S.
    Markin, Alexey V.
    Sarmini, Yuliya A.
    Smirnova, Natalia N.
    Boldyrev, Konstantin L.
    Tatarinova, Elena A.
    Meshkov, Ivan B.
    Muzafarov, Aziz M.
    JOURNAL OF CHEMICAL THERMODYNAMICS, 2021, 153
  • [34] iMac G5
    李寒
    吴敌
    个人电脑, 2004, (12) : 210 - 211
  • [35] Stoichiometry and equilibrium constant of the complex of PAMAM-NH2 G4 and 5-fluorouracil
    Buczkowski, Adam
    Piekarski, Henryk
    Palecz, Bartlomiej
    JOURNAL OF MOLECULAR LIQUIDS, 2012, 173 : 8 - 12
  • [36] Characterization of G4 PAMAM dendrimer complexes with 5-fluorouracil and their interactions with bovine serum albumin
    TokarczyK, Karolina
    Jachimska, Barbara
    COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2019, 561 : 357 - 363
  • [37] 奥轩GX5 源于G5胜于G5
    蔺天子
    中国汽车市场, 2012, (13) : 7 - 7
  • [38] Hyperchloremic acidosis develops at the stage G4 and shifts to high anion gap acidosis at the stage G5 in chronic kidney disease
    Masayuki Tanemoto
    Ryohei Kamachi
    Takahide Kimura
    Seiki Yamada
    Takeshi Yokoyama
    Yukio Okazaki
    Clinical and Experimental Nephrology, 2020, 24 : 1140 - 1143
  • [39] Hyperchloremic acidosis develops at the stage G4 and shifts to high anion gap acidosis at the stage G5 in chronic kidney disease
    Tanemoto, Masayuki
    Kamachi, Ryohei
    Kimura, Takahide
    Yamada, Seiki
    Yokoyama, Takeshi
    Okazaki, Yukio
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (12) : 1140 - 1143
  • [40] DAA Therapy in Hepatitis C in Patients With Chronic Kidney Disease: New Information for GFR Category G4 and G5 Reply
    Awan, Ahmed A.
    Jadoul, Michel
    Martin, Paul
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 247 - 247
12345